Company Filing History:
2 out of 721 
2 out of 378 
Years Active: 2019-2020
Title: Cornelia Preusse: Innovator in Pharmaceutical Research
Introduction
Cornelia Preusse is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of two patents to her name, her work focuses on addressing hyperproliferative diseases.
Latest Patents
Cornelia's latest patents include "Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases." These compounds, represented by formula (I), are designed to inhibit Bub1 kinase, showcasing their potential as pharmaceuticals. The processes for their production and application further highlight the innovative nature of her work.
Career Highlights
Throughout her career, Cornelia has worked with prominent companies in the pharmaceutical industry, including Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in her field.
Collaborations
Cornelia has collaborated with esteemed colleagues such as Marion Hitchcock and Anne Mengel. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Cornelia Preusse stands out as a dedicated inventor whose work in kinase inhibitors is paving the way for new treatments in the pharmaceutical industry. Her contributions are vital in the ongoing fight against hyperproliferative diseases.